Desloratadine and depression, a drug safety signal based on worldwide spontaneous reporting of side effects

Objective: Desloratadine, a third-generation antihistamine, is claimed to cause fewer central nervous system (CNS) adverse drug reactions (ADRs) than antihistamines of the first- and second-generation. While literature is inconclusive regarding the possible CNS effects, symptoms like somnolence and...

Descripción completa

Detalles Bibliográficos
Autores principales: Boer, Jeltje, Ederveen, Ellen, Grundmark, Birgitta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198223/
https://www.ncbi.nlm.nih.gov/pubmed/30084285
http://dx.doi.org/10.1080/03009734.2018.1489918

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198223/
https://www.ncbi.nlm.nih.gov/pubmed/30084285
http://dx.doi.org/10.1080/03009734.2018.1489918

Ejemplares similares